13 studies found for:    michaelson
Show Display Options
Rank Status Study
1 Recruiting Tivozanib + Enzalutamide in Adv Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Tivozanib;   Drug: Enzalutamide
2 Recruiting Individually Tailored Web-based Multimodal Pain Rehabilitation in Primary Health Care
Condition: Musculoskeletal Pain
Intervention: Behavioral: Web-based multimodal rehabilitation based on cognitive based principles
3 Completed
Has Results
ET 743 (Yondelis) in Men With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: ET 743
4 Completed
Has Results
Study of SU11248 in Men With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Sunitinib
5 Completed Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Condition: Cancer
Intervention:
6 Completed Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Bladder Urothelial Carcinoma;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: Paclitaxel;   Biological: Trastuzumab;   Radiation: Radiation Therapy
7 Active, not recruiting Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
8 Completed
Has Results
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Neoplasm Metastases
Interventions: Drug: Gemcitabine;   Drug: Sunitinib
9 Withdrawn Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Sunitinib;   Drug: Bevacizumab
10 Recruiting S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: everolimus;   Drug: exemestane;   Drug: goserelin acetate;   Drug: letrozole;   Drug: leuprolide acetate;   Drug: tamoxifen citrate;   Other: placebo
11 Recruiting Interactive Web-based Program and CBT-coaching With Physiotherapy for Patients With Chronic Musculoskeletal Pain
Condition: Musculoskeletal Pain
Interventions: Behavioral: Web-prog, followed by CBT + PT;   Behavioral: Base, followed by Web + CBT + PT
12 Recruiting Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Ductal Breast Carcinoma In Situ;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Invasive Breast Carcinoma;   Multicentric Breast Carcinoma;   Multifocal Breast Carcinoma;   Synchronous Bilateral Breast Carcinoma
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Drug: Systemic Chemotherapy;   Drug: Tamoxifen Citrate
13 Not yet recruiting Exploratory Study of Radium-223 and Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Metastases
Condition: Metastatic Renal Cell Carcinoma
Interventions: Drug: Pazopanib;   Drug: Sorafenib;   Drug: Radium-223

Indicates status has not been verified in more than two years